Clinical Trial Update: The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk [NA]

View source ↗

Summary

This clinical trial update describes the SENTINL-1 study, which evaluates patient-reported outcomes related to AI-inferred lung cancer risk and is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Lung Cancer | NA | Status: RECRUITING